Motley Fool Asset Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.48M | Sell |
|
|||||
|
2025
Q2 | $6.09M | Buy |
|
|||||
|
2025
Q1 | $3.06M | Buy |
|
|||||
|
2024
Q4 | $2.04M | Sell |
|
|||||
|
2024
Q3 | $8M | Buy |
|
|||||
|
2024
Q2 | $5.81M | Sell |
|
|||||
|
2024
Q1 | $6.84M | Sell |
|
|||||
|
2023
Q4 | $7.15M | Sell |
|
|||||
|
2023
Q3 | $5.57M | Buy |
|
|||||
|
2023
Q2 | $4.23M | Buy |
|
|||||
|
2023
Q1 | $1.39M | Sell |
|
|||||
|
2022
Q4 | $1.71M | Sell |
|
|||||
|
2022
Q3 | $1.66M | Sell |
|
|||||
|
2022
Q2 | $5.25M | Sell |
|
|||||
|
2022
Q1 | $6.38M | Sell |
|
|||||
|
2021
Q4 | $10.1M | Sell |
|
|||||
|
2021
Q3 | $12.1M | Sell |
|
|||||
|
2021
Q2 | $16.3M | Buy |
|
|||||
|
2021
Q1 | $17.3M | Buy |
|
|||||
|
2020
Q4 | $7.66M | Buy |
|
|||||
|
2020
Q3 | $3.89M | Buy |
|
|||||
|
2020
Q2 | $3.31M | Buy |
|
|||||
|
2020
Q1 | $1.28M | Buy |
|